Literature DB >> 25787156

The Medical Symptom Validity Test Measures Effort Not Ability in Children: A Comparison Between Mild TBI and Fetal Alcohol Spectrum Disorder Samples.

Jennifer C Gidley Larson1, Lloyd Flaro2, Robin L Peterson3, Amy K Connery3, David A Baker3, Michael W Kirkwood4.   

Abstract

Inadequate effort during neuropsychological examination results in inaccurate representations of an individual's true abilities and difficulties. As such, performance validity tests (PVTs) are strongly recommended as standard practice during adult-based evaluations. One concern with using PVTs with children is that failure reflects immature cognitive ability rather than non-credible effort. The current study examined performance on the Medical Symptom Validity Test (MSVT) in two large pediatric clinical samples with strikingly different neuropsychological profiles: (1) mild traumatic brain injury (mTBI; n = 510) and (2) fetal alcohol spectrum disorder (FASD; n = 120). Despite higher IQ scores and reading ability, the mTBI group performed significantly worse than the FASD group on all effort indices. Sixteen percent of the mTBI group failed the MSVT, whereas only 5% of the FASD group did. Our findings support the idea that the MSVT measures effort, not ability, in most cases and help to justify incorporating PVTs into pediatric neuropsychological batteries.
© The Author 2015. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Children; MSVT; Performance validity testing; Symptom validity testing; Traumatic brain injury

Mesh:

Year:  2015        PMID: 25787156     DOI: 10.1093/arclin/acv012

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  1 in total

1.  Prospective Exploration of Cognitive-Communication Changes With Woodcock-Johnson IV Before and After Sport-Related Concussion.

Authors:  Kathryn Y Hardin
Journal:  Am J Speech Lang Pathol       Date:  2021-03-30       Impact factor: 2.408

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.